A homegrown innovation ecosystem is taking root

1. At a Glance

• India's innovation ecosystem is transitioning from a technology-importing, services-driven economy to one with indigenous R&D capacity spanning public research institutions, corporate R&D, and deep-tech startups [1].
• Patent filing data is used as the headline indicator of this shift — 1,43,729 filings in FY 2025-26, up 30.2% from 1,10,375 in FY 2024-25, with domestic applicants accounting for ~69% (nearly 7 in 10) of filings [1][2].
• Strategic-technology domains — Gallium Nitride (GaN) semiconductors (radar, space, next-gen communications) and affordable immunotherapies for cancer care — are cited as flagship cases of homegrown deep-tech and biomedical innovation [1].
• Relevant for Prelims (patent statistics, schemes) and Mains GS-III (science & tech, indigenization, IPR).

2. Why in the News

• The Hindu BusinessLine (19 September 2026) analysis notes that three institutional pillars — public research, corporate R&D, deep-tech entrepreneurship — are now advancing together, citing GaN semiconductor development and indigenous immunotherapies as proof points [1].
• Trigger data point: Commerce Minister Piyush Goyal announced record patent filings for FY 2025-26 (1,43,729, up 30.2%), the highest ever, positioning India among the top patent-filing nations globally [2].

3. Background & Evolution

• India's patent filings were under 50,000 in FY 2015-16; the last five years have seen a cumulative rise of roughly 146%, reflecting a structural shift often described as "Made in India" moving toward "Invented in India" [2].
• GaN ecosystem building: the GaN Ecosystem Enabling Centre and Incubator (GEECI) at IISc Bengaluru, implemented through the Foundation for Science Innovation and Development (FSID) with an outlay of ~₹334 crore, funded by the Ministry of Electronics and Information Technology (MeitY), was set up to build end-to-end GaN electronics manufacturing capacity for high-power, high-frequency RF electronics [3].
• AGNIT Semiconductors, incubated at this MeitY-funded GaN foundry, is cited as India's first GaN semiconductor technology startup, building on over 15 years of R&D originating at IISc [3].
• The broader semiconductor policy architecture includes the India Semiconductor Mission (ISM) and the Design Linked Incentive (DLI) scheme to encourage startups to own IP-based chip designs; the government has since approved "Semicon 2.0", the second phase of the national semiconductor strategy, covering 12 approved manufacturing projects including integrated GaN and microLED facilities [3].
• Predecessor policy strands include India's IPR promotion measures — reduced filing fees for startups, MSMEs, and educational institutions, fast-track examination, and pro bono IP support schemes — which lowered entry barriers for grassroots innovators [2].

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic

• Domestic deep-tech and IP creation reduce reliance on imported technology, building sovereign capacity in strategic sectors like semiconductors [1].
• Strong state-level clustering (Tamil Nadu, Karnataka, Maharashtra) reflects industrial base and startup density driving patent growth [2].

Scientific / Technological

• GaN is a wide-bandgap semiconductor critical for radar, space systems, and next-gen (5G/6G) communications — a strategically export-controlled technology area where India is building indigenous capability [1][3].
• Rising indigenous immunotherapy development signals growing biomedical/biotech innovation capacity, improving affordability of advanced cancer treatment [1].

Geopolitical / Strategic

• GaN technologies are tied to tightly regulated, export-controlled global supply chains (dual-use for defence/space); domestic capability narrows a strategic dependency gap [1].
• Semiconductor self-reliance aligns with India's positioning in critical and emerging technology partnerships (e.g., with the US) amid global chip supply-chain realignment [1][3].

Governance / Administrative

• Institutional architecture spans three pillars — public research institutes (e.g., IISc), corporate R&D, and startups — coordinated through targeted schemes (ISM, DLI, GEECI) rather than a single unified body [1][3].
• Fee reductions, fast-track examination, and pro bono IP assistance for startups/MSMEs/academia are administrative levers used to raise patent filing volumes [2].

Ethical / Critical Caveat

• Analysts caution that rising patent volume alone does not indicate quality or commercialisation success — filing numbers are a proxy, not a complete measure of innovation impact [1].

6. Recent Developments (last 12-18 months)

• April 2026: Commerce Minister Piyush Goyal announced record patent filings of 1,43,729 for FY 2025-26, a 30.2% year-on-year increase [2].
• 2025-26: AGNIT Semiconductors, India's first GaN semiconductor startup, won recognition at NASSCOM's Deep Tech Emerge 50 Awards 2025 [3].
• 2026: Government approved "Semicon 2.0", the second phase of the national semiconductor strategy, sanctioning 12 manufacturing projects including integrated GaN and microLED facilities [3].
• 19 September 2026: The Hindu BusinessLine published an analysis framing India's "homegrown innovation ecosystem" around GaN semiconductors, immunotherapies, and record patent growth [1].

7. Prelims Hooks

• India's patent filings hit a record 1,43,729 in FY 2025-26, up 30.2% from FY 2024-25 [2].
• Domestic applicants filed ~69% of India's patents in FY 2025-26 [1][2].
• India's patent filings were under 50,000 in FY 2015-16, growing ~146% in the last five years [2].
• GaN Ecosystem Enabling Centre and Incubator (GEECI) is located at IISc Bengaluru [3].
• GEECI is implemented through the Foundation for Science Innovation and Development (FSID) with an outlay of ~₹334 crore [3].
• The GaN foundry/incubator is funded by the Ministry of Electronics and Information Technology (MeitY), not the Department of Science and Technology [3].
• AGNIT Semiconductors is described as India's first Gallium Nitride semiconductor technology startup [3].
• The Design Linked Incentive (DLI) Scheme operates under the India Semiconductor Mission (ISM) to support IP-owned chip design startups [3].
• "Semicon 2.0" is the second phase of India's national semiconductor strategy, approving 12 manufacturing projects including GaN and microLED facilities [3].
• GaN semiconductors are significant for radar, space systems, and next-generation communications and belong to a tightly export-controlled technology category [1].
• Leading states in patent filings: Tamil Nadu, Karnataka, and Maharashtra [2].
• The three institutional pillars of India's innovation economy identified: public research, corporate R&D, and deep-tech entrepreneurship [1].

8. Filing a Patent Is Not the Same as Owning a Technology

• A filing is only an application. A grant is the actual right.
• The 1,43,729 figure counts applications made in FY 2025-26 [2]. It does not count patents given.
• Anyone can file. Only an examiner at the patent office can grant, after checking the invention is new and useful.

• So a 30.2% jump in filings tells us more people are trying. It does not yet tell us more inventions passed the test.

• The gap between the two is the examination queue, and the queue is long

• In India the average wait for a final decision on a patent was about 50 months — over four years [5].
• Japan decides about three times faster than India [5].

• Around 1.7 lakh applications were sitting unexamined as of April 2023 — more than a full year of filings at today's rate [5].

• Why the queue does not clear: too few examiners for too many files

• In 2020 there were over 1,60,000 pending applications and only about 858 examiners to read them [5].
• Earlier the shortage was worse — in June 2015, of 337 examiner posts, only 130 were actually filled [5].

• One examiner cannot read faster to fix this. Volume rose; staff did not rise with it.

• Why this matters for a startup, in money terms

• A deep-tech startup like AGNIT cannot easily raise money or license its design to a customer while the patent is still only an application [3].
• Four years of waiting is longer than the life of many startups. The delay itself decides who survives.

9. The Number Nobody Quotes: India Spends 0.64% of GDP on Research

• Patents are the output. Research money is the input — and that input is small.
• India's GERD (Gross Expenditure on Research and Development — all money spent on R&D by government, industry and universities together) is about 0.64% of GDP [4].
• Filings grew ~146% in five years [2], but this spending share has stayed roughly flat for years [4].

• A rising count of applications built on a flat research budget usually means cheaper, smaller inventions — not more expensive, harder ones.

• Who is not spending: Indian industry

• In India, private industry pays for well under half of all R&D; the government pays for most of it [4].
• In most advanced economies the reverse is true — companies pay for the bigger share.

• This matters because companies fund the last and costliest step: turning a lab result into a product people buy. Government money usually stops before that step.

• So the three pillars are not equally strong

• The note lists public research, corporate R&D and startups as three pillars advancing together [1].
• On the spending data, the corporate pillar is the thinnest of the three [4]. A patent surge cannot hide that.

10. Why a GaN Foundry Alone Will Not Make a GaN Industry

• The slow part is not invention. It is the walk from lab to factory.
• AGNIT's technology came out of over 15 years of R&D at IISc before it became a startup [3].

• Fifteen years is the real timeline for deep-tech. A one-year jump in patent filings cannot be read as proof that this walk has got faster.

• GaN chips need a buyer before they need a factory

• GaN is used mainly in radar, space systems and next-generation communications [1][3]. These are not consumer goods sold in a shop.
• Almost all the buyers are government or government-linked — defence, space, telecom.

• So if those buyers keep importing, an Indian GaN line runs below capacity no matter how good the technology is. The chip has no other market to fall back on.

• Incentives are aimed at design, but the hard dependency is upstream

• The DLI (Design Linked Incentive) scheme under ISM supports startups that own their chip designs [3].
• Semicon 2.0 adds manufacturing plants, including integrated GaN facilities [3].
• Neither owns the equipment, the ultra-pure materials or the process tools that a fab runs on — and GaN sits in a tightly export-controlled category, so those inputs can be restricted by other countries [1][3]. Building the fab reduces one dependency and leaves another in place.

11. The Honest Case for Taking the Patent Jump Seriously

• The strongest argument against all the above: the 69% domestic share is not a statistical trick [1][2].
• Resident (domestic) filing share is the standard measure innovation bodies use to see whether invention is happening inside a country or only being registered there by foreign firms.

• For most of India's history, foreign applicants dominated Indian patent filings. Nearly 7 in 10 filings now being domestic is a genuine reversal [1][2].

• And it is not only about fee discounts.

• Cheaper filing fees and fast-track examination for startups, MSMEs and colleges did push volumes up [2].

• But fee cuts cannot explain a hard-technology result like a working GaN device line at IISc, or an indigenous immunotherapy [1][3]. Those needed real laboratories and long funding.

• Where the argument still falls short

• It shows more people are inventing. It does not yet show the inventions are being sold.
• Both things can be true: the base has widened genuinely, and the output stage — grant, licence, product — is still blocked [4][5].

12. Fixes With a Named Owner: Examiners, Patient Money, First Buyers

• The patent office (CGPDTM) should fill examiner posts before it advertises filing numbers
• The bottleneck is countable: ~1.7 lakh pending files against ~858 examiners [5].
• The government's own plan was to reach about 963 examiners and 998 controllers by FY26 [5]. The right question in a Mains answer is whether that target was met, not whether filings rose.

• Fast-track examination for startups only helps if there are people to do the examining [2].

• ANRF should use the RDI Scheme to pay for the stage where private money refuses to go

• The RDI (Research, Development and Innovation) Scheme offers long-tenure, low or nil interest financing to private firms in strategic and sunrise sectors [6].
• This is aimed exactly at the weak link — the costly step of taking a proven lab result and scaling it [6].

• It works only if it funds scale-up, not more early-stage grants, which India already has.

• MeitY and the defence/space buyers should commit to buying Indian GaN, not only to funding it

• MeitY has already paid to build the capacity — ~₹334 crore for GEECI at IISc [3].
• A guaranteed first order from a domestic radar or space programme gives a startup like AGNIT predictable revenue, which no incentive scheme can substitute for [3].

• Build-and-hope leaves an expensive fab idle; build-and-buy keeps it running.

• Publish grants and commercialisation alongside filings

• Today the headline released is filings [2]. Grants, average pendency and licensing income are the numbers that show whether innovation reached a user [5].
• Until those are reported together, the filing figure will keep being read as more than it is.

13. Anchors for Answers

• Data: 1,43,729 patent filings in FY 2025-26, up 30.2%, with ~69% from domestic applicants [1][2]
• Data: India's GERD is about 0.64% of GDP, with private industry funding well under half of it [4]
• Data: ~50 months average wait for a final patent decision; ~1.7 lakh applications pending against ~858 examiners [5]
• Comparison: Japan decides patent applications about three times faster than India [5]
• Scheme: RDI Scheme (₹1 lakh crore corpus, administered through ANRF) — long-tenure low-interest finance for private R&D in strategic and sunrise sectors [6]
• Scheme: Design Linked Incentive (DLI) under India Semiconductor Mission, plus Semicon 2.0's 12 approved projects including integrated GaN facilities [3]
• Case study: AGNIT Semiconductors — over 15 years of IISc research before becoming India's first GaN startup; the real lab-to-market timeline [3]

14. Mains Relevance

• GS-III: Science and Technology — indigenization of technology, developments in IT, space, computers, biotechnology; Indian Intellectual Property Rights (IPR) regime; Infrastructure — energy/technology self-reliance.
• GS-II (secondary linkage): Government policies and interventions for development in science/tech sectors.
• Possible Mains question stems: 1. Rising patent filings are often cited as evidence of a maturing innovation ecosystem. Critically examine whether patent volume is a sufficient indicator of genuine technological self-reliance in India. (GS-III) 2. Discuss the strategic significance of indigenous Gallium Nitride (GaN) semiconductor development for India's defence and space capabilities. (GS-III) 3. Examine the roles of public research institutions, corporate R&D, and deep-tech startups in building a homegrown innovation ecosystem in India. What administrative bottlenecks constrain their convergence? (GS-II/III)

15. Related Topics to Study Next

• India Semiconductor Mission (ISM) & Semicon India Programme — parent policy framework for GaN/chip manufacturing incentives.
• Design Linked Incentive (DLI) Scheme — direct link to startup chip-design support mentioned here.
• National IPR Policy, 2016 — governs India's patent/trademark ecosystem and fee-reduction measures for startups.
• Startup India & Deep Tech Startup Policy — institutional ecosystem for translating research into enterprise.
• Atmanirbhar Bharat in strategic technologies — broader self-reliance narrative covering defence, space, semiconductors.
• India's Global Innovation Index (GII) ranking — comparative benchmark for innovation performance.
• Export control regimes (Wassenaar Arrangement, MTCR) — context for why GaN/dual-use tech is tightly regulated globally.
• Biotechnology and immunotherapy R&D ecosystem in India — parallel biomedical innovation case cited in the article.

16. Common Errors / Trap Areas

• Do not confuse MeitY (funds the GaN foundry/GEECI) with the Department of Science and Technology (DST) — a common ministry-mix-up trap.
• Distinguish patent filings (applications made) from patents granted — the 30.2% figure refers to filings, not grants; do not conflate the two in Mains answers.
• GEECI/AGNIT is based at IISc Bengaluru, not a government lab like CSIR or DRDO — avoid attributing it to a central government R&D institute.
• "Semicon 2.0" is the second phase of India's semiconductor strategy — do not confuse it with the original 2021 India Semiconductor Mission launch.
• Domestic applicant share (~69%) is a proportion of total filings, not total patents granted or R&D expenditure share — keep the metric precise for Prelims-style questions.